Competitive: Chemistree Solutions: Primary Care Representative – Diabetes and Respiratory...
Author - David Miller
Chemistree Solutions: Sales Representative
Competitive: Chemistree Solutions: Primary Care Representative – Diabetes and Respiratory...
Preclinical study: after heart attack, a boost in...
A scientific technique that rapidly increases the body's production of anti-inflammatory cells...
FDA Approves Qfitlia (fitusiran) to Treat Hemophilia A or B With...
Paris, March 28, 2025. The US Food and Drug Administration (FDA) has approved Qfitlia (fitusiran)...
FDA Approves Imfinzi (durvalumab) for Muscle Invasive Bladder...
On March 28, 2025, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) with...
FDA Approves Novartis Radioligand Therapy Pluvicto for Earlier...
Basel, March 28, 2025 – Novartis announced today that the US Food and Drug Administration (FDA)...
Galderma: Regional Head of Ecommerce and Digital Marketing, EMEAC
Competitive: Galderma: We are seeking a dynamic and experienced Regional Head of Ecommerce and...
Galderma: Executive Account Manager, Immunology –...
Competitive: Galderma: Immunology Account Manager is responsible for achieving/exceeding Galderma...
Bayer and Puhe BioPharma enter into global license agreement for...
Bayer and Suzhou Puhe BioPharma Co., Ltd., a clinical-stage biotechnology company, announced that...
FDA Approves Bomyntra (denosumab-bnht), a Biosimilar to Xgeva
LAKE ZURICH, Ill., March 27, 2025 — Fresenius announced that the Biologics License...